<DOC>
	<DOCNO>NCT02280863</DOCNO>
	<brief_summary>The primary objective pilot study evaluate safety efficacy hybrid close loop ( HCL ) system participant type 1 diabetes . This HCL system utilizes PID-IFB controller day night closely monitor outpatient environment allow assessment practical aspect use system participant diabetes parent designate remote monitor .</brief_summary>
	<brief_title>Hybrid Closed-Loop Hotel Studies With Medtronic PID Controller</brief_title>
	<detailed_description>Study participant ask use CGM study insulin pump provide approximately 3 7 day prior initiation HCL PID-IFB system . All participant diabetes parent/ guardian participant &lt; 18 year age ask stay overnight hotel HCL PID-IFB system remain close Stanford University day . For participant &gt; 18 year age , designate remote monitor ask receive alert low/ high glucose level . In order ass user experience/ evaluation system participant diabetes use HCL parent/ legal guardian participant &lt; 18 year age designate remote monitor participant &gt; 18 year age also ask provide consent participate evaluation .</detailed_description>
	<criteria>Clinical diagnosis type 1 diabetes ( The diagnosis type 1 diabetes base investigator 's judgment ; C peptide level antibody determination need . ) Daily insulin therapy least one year Age 14.0 40.0 year age . The first 9 subject ( 3 center ) 18 year old . Subject perform average least 3 meter glucose reading per day precede 2 week Subject use downloadable insulin pump least 3 month Subject comprehends write English Female patient sexually active must acceptable method contraception e.g . oral contraceptive pill , diaphragm , IUD Female patient must negative urine pregnancy test Informed Consent Form sign subject and/or parent assent sign subject &lt; age 18 Parent/guardian ( subject &lt; 18 year ) subject understand study protocol agree comply . Both parent must sign possible . Total daily insulin requirement great 0.4 units/kg/day precede two week . No expectation subject move area clinical center study . Adults need work within 20 minute research staff day . A person willing fulfill role remote monitor ( parent , spouse significant ) . Subject medical disorder judgment investigator affect wear device completion aspect protocol Diabetic ketoacidosis past month History seizure loss consciousness last 6 month Subject respiratory condition asthma , treat systemic inhaled corticosteroid previous 6 month cystic fibrosis Subject history cardiac vascular disorder myocardial infarction , unstable angina , coronary artery bypass surgery , coronary artery stenting , transient ischemic attack , cerebrovascular accident , angina , congestive heart failure , arrhythmia thromboembolic disease Subject history liver kidney disease ( microalbuminuria ) Systolic blood pressure &gt; 140 mmHg screen visit Diastolic blood pressure &gt; 90 mmHg screen visit Subject active Graves ' disease Subjects inadequately treat thyroid disease celiac disease Subject neurologic disorder judgment investigator affect completion protocol Either subject subject 's primary caregiver receive inpatient psychiatric treatment past 6 month Subject history diagnose medical eat disorder Subject history know illicit drug abuse Subject history know prescription drug abuse Subject history current alcohol abuse Subject history visual impairment would allow subject participate Subject active skin condition would affect sensor placement Subject adhesive allergy Subjects require intermediate longacting insulin ( NPH , detemir glargine ) Subjects require antidiabetic medication insulin ( oral injectable ) Current use oral/inhaled glucocorticoid medication , judgment investigator would contraindication participation study Subject currently beta blocker medication Subject currently participate another investigational study ( drug device ) Subject deem investigator unwilling unable follow protocol</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>